Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 1
1955 1
1960 1
1963 1
1970 3
1971 4
1972 1
1976 1
1977 2
1978 1
1980 2
1984 1
1985 1
1986 1
1989 1
1993 1
1995 1
2009 1
2010 1
2011 2
2012 3
2013 1
2014 2
2015 4
2016 1
2017 1
2018 3
2019 2
2020 2
2021 8
2022 2
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Comprehensive description of the prevalence, serological and clinical characteristics, and visceral involvement of systemic sclerosis (scleroderma) in a large cohort from the United Arab Emirates Systemic Sclerosis Registry.
Namas R, Elarabi M, Khan S, Mubashir A, Memisoglu E, El-Kaissi M, Joshi A, Chapman J, Jassim I, Khogali H, Hassan N, Sabbour H, Saleh K, Alnaqbi KA, Zayat AS, Diab S, Awir Z, Abu Taha N, Ginawi A, Al Ansari A, Rifaai H, Alrawi Z, Al Dhaheri A, Ibrahim G, Abogamal A, Al Shehhi W, Teir J, Khan T, Musgrave M, Hameed B, Khan B, Mosallam N, Hussien N, Hussein I, Abdulelhamid A, Ali A, Hannawi S, Al Izzi M, Badsha H, Al Saleh J. Namas R, et al. Among authors: zayat as. J Scleroderma Relat Disord. 2023 Jun;8(2):137-150. doi: 10.1177/23971983221145788. Epub 2023 Jan 5. J Scleroderma Relat Disord. 2023. PMID: 37287950
Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials.
Rivellese F, Nerviani A, Giorli G, Warren L, Jaworska E, Bombardieri M, Lewis MJ, Humby F, Pratt AG, Filer A, Gendi N, Cauli A, Choy E, McInnes I, Durez P, Edwards CJ, Buch MH, Gremese E, Taylor PC, Ng N, Cañete JD, Raizada S, McKay ND, Jadon D, Sainaghi PP, Stratton R, Ehrenstein MR, Ho P, Pereira JP, Dasgupta B, Gorman C, Galloway J, Chinoy H, van der Heijde D, Sasieni P, Barton A, Pitzalis C; STRAP collaborative group. Rivellese F, et al. Lancet Rheumatol. 2023 Nov;5(11):e648-e659. doi: 10.1016/S2665-9913(23)00241-2. Lancet Rheumatol. 2023. PMID: 38251532 Free article. Clinical Trial.
Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status.
Md Yusof MY, Psarras A, El-Sherbiny YM, Hensor EMA, Dutton K, Ul-Hassan S, Zayat AS, Shalbaf M, Alase A, Wittmann M, Emery P, Vital EM. Md Yusof MY, et al. Among authors: zayat as. Ann Rheum Dis. 2018 Oct;77(10):1432-1439. doi: 10.1136/annrheumdis-2018-213386. Epub 2018 Jun 21. Ann Rheum Dis. 2018. PMID: 29929956 Free PMC article.
59 results